| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.6 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | -0.073 | 0.6 |